CSF2 and neoplasm: CRISPR can be employed to knock out virulence genes, insert safety switches, or engineer bacterial payloads that secrete immune-stimulating cytokines (e.g., IL-12, GM-CSF), tumor-selective toxins, or checkpoint inhibitors directly within the tumor microenvironment [219].